ACE and cardiovascular disorder: Cardiovascular disease remains the leading cause of morbidity and mortality worldwide and whilst current drugs (e.g. angiotensin-converting enzyme inhibitors, beta blockers) improve symptoms and reduce hospital admissions, the prevalence of cardiovascular disease is still increasing, highlighting the need for the identification of novel and efficacious therapies that can prevent cardiovascular disease.